News & Events

Cooperation with Harvard Medical School (MGH)

27 Oct|

ISK has signed an agreement for cooperation with Harvard Medical School for drug development to treat neurodegenerative diseases

Prof. Marc E. Lippman – Famous breast cancer expert (KOL ) has joined ISK Ltd

09 Apr|

Marc E. Lippman, MD, MACP FRCP is the Kathleen and Stanley Glaser Professor of Medicine at the University of Miami Leonard School of Medicine, and was Chairman of the Department of Medicine from May 2007 to May 2012. He is currently Deputy Director of the Sylvester Comprehensive Cancer Center. Previously Dr. Lippman was the John

ISK attended the 2019 Sachs conference in Zurich

05 Mar|

Prof. Rosenblatt, Joseph D, M.D, a KOL in hematology, has joined ISK’s advisory board

25 Feb|

Prof. Joseph D Rosenblatt
Joseph D Rosenblatt is Professor of Medicine, Microbiology and Immmunology at the University of Miami Miller School of Medicine , and currently serves as the William Harrington Professor of Hematology and Chief of the University of Miami Division of Hematology.
He previously served as chief of the combined Division of Hematology – Oncology

Nerofe has received a new US patent for metastatic cancer treatment

21 Nov|

Phase2a Nerofe study has begun in Rabin and Kaplan medical centers

21 Sep|

Phase2a Nerofe study has begun in Rabin and Kaplan medical centers

PMWC 2018 conference – New Technology Presented

04 Feb|

At  PMWC 2018 conference Dr. Yoram Devary presented ISK new technology dealing with “personalized ImmunoOncology therapy” 

New Article Published: Nerofe Phase I trial summary

11 Dec|

The Phase I Nerofe (dTCApFs) human trial summary has been published in the Molecular and Clinical Oncology Journal.

In this trial Nerofe was found to be safe and well‑tolerated, and potentially efficacious as an anti-cancer agent.

Successful completion of Phase I Nerofe Trial on Solid tumors

21 Nov|

Successful completion of Phase I Nerofe Trial on Solid tumors

Nerofe Pre-clinical Paper Published in Molecular and Clinical Oncology Journal

21 Oct|

Link To Article